Skip to content

Mannkind MNKD Price / earnings

Price / earnings at other companies

Eli Lilly logo
Eli LillyLLY
32.5×-34.3×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
105.5×
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
50.4×
Merit Medical Systems logo
Merit Medical SystemsMMSI
29.4×-21.5×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
13.7×-1.3×
Abbott logo
AbbottABT
28.4×+11.4×

Other financials

Income statement

See full
Revenue$90.2M+15.1%
Gross profit$82.7M+10.8%
Operating income-$1.7M-107%
Net income-$16.6M-226%
EPS (diluted)-$0.05-225%

Balance sheet

See full
Cash & equivalents$52.8M+11.7%
Total debt$12.2M-9.4%
Total equity-$59.2M-1.0%
Total assets$744.4M+81.5%

Cash flow

See full
Operating cash flow-$5.4M+15.9%
CapEx$1.9M+470%
Free cash flow-$7.2M-8.0%

Valuation

See full
Market cap$1.19B+3.5%
Enterprise value$1.15B+3.0%
P/S3.3×-0.6×

Profitability

See full
Gross margin91.5%-2.6pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity-8.8%
Debt / equity-0.2×
Current ratio1.9×-0.5×

Where this comes from

Calculated from Mannkind’s reported figures.

Based on the most recent quarter.

The official record: Mannkind’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Mannkind's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mannkind's price / earnings?
Mannkind (MNKD) reported price / earnings of 56.4× in Q3 2025.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.